Psyche Pllc | |
5240 E Knight Dr Ste 120 Tucson AZ 85712-2122 | |
(520) 795-0309 | |
(520) 795-2030 |
Full Name | Psyche Pllc |
---|---|
Speciality | Psychiatry & Neurology |
Location | 5240 E Knight Dr Ste 120, Tucson, Arizona |
Authorized Official Name and Position | Adriana-maria Boiangiu (PSYCHIATRY/ OWNER) |
Authorized Official Contact | 9739025563 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Psyche Pllc 5240 E Knight Dr Ste 120 Tucson AZ 85712-2122 Ph: (520) 795-0309 | Psyche Pllc 5240 E Knight Dr Ste 120 Tucson AZ 85712-2122 Ph: (520) 795-0309 |
NPI Number | 1003295619 |
---|---|
Provider Enumeration Date | 05/28/2015 |
Last Update Date | 07/27/2015 |
Medicare PECOS PAC ID | 7517272586 |
---|---|
Medicare Enrollment ID | O20150819009461 |
News Archive
Miller-McCune examines the limited access populations living in Africa have to the schistosomiasis drug praziquantel the only commercially available treatment for the disease.
Evotec AG today announced that its research alliance with Boehringer Ingelheim has reached a milestone, triggering a payment of EUR 2.5 million to Evotec. The milestone reached was the selection of a candidate compound for pre-development studies in an inflammation and immunology programme.
Cordis Corporation, a Johnson & Johnson company, announced today that it has reached an agreement with Boston Scientific resolving two Delaware litigations related to Cordis's Palmaz and Gray patents and Boston Scientific's Jang patents.
The dangers of passive smoking are even more pronounced among young people carrying common gene defects, researchers at the University of Dundee have found.
Independent research organisation MindMetre, which regularly addresses patient and healthcare worker safety across Europe, has examined evidence from qualitative interviews, clinical research and case studies that harm is being sustained by chemotherapy nurses in UK NHS Trusts as a result of exposure to hazardous cytotoxic drugs.
› Verified 9 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1003295619 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 45341 (Arizona) | Primary |
Provider Name | Adriana Maria Boiangiu |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1396024741 PECOS PAC ID: 7214100205 Enrollment ID: I20111108000586 |
News Archive
Miller-McCune examines the limited access populations living in Africa have to the schistosomiasis drug praziquantel the only commercially available treatment for the disease.
Evotec AG today announced that its research alliance with Boehringer Ingelheim has reached a milestone, triggering a payment of EUR 2.5 million to Evotec. The milestone reached was the selection of a candidate compound for pre-development studies in an inflammation and immunology programme.
Cordis Corporation, a Johnson & Johnson company, announced today that it has reached an agreement with Boston Scientific resolving two Delaware litigations related to Cordis's Palmaz and Gray patents and Boston Scientific's Jang patents.
The dangers of passive smoking are even more pronounced among young people carrying common gene defects, researchers at the University of Dundee have found.
Independent research organisation MindMetre, which regularly addresses patient and healthcare worker safety across Europe, has examined evidence from qualitative interviews, clinical research and case studies that harm is being sustained by chemotherapy nurses in UK NHS Trusts as a result of exposure to hazardous cytotoxic drugs.
› Verified 9 days ago
News Archive
Miller-McCune examines the limited access populations living in Africa have to the schistosomiasis drug praziquantel the only commercially available treatment for the disease.
Evotec AG today announced that its research alliance with Boehringer Ingelheim has reached a milestone, triggering a payment of EUR 2.5 million to Evotec. The milestone reached was the selection of a candidate compound for pre-development studies in an inflammation and immunology programme.
Cordis Corporation, a Johnson & Johnson company, announced today that it has reached an agreement with Boston Scientific resolving two Delaware litigations related to Cordis's Palmaz and Gray patents and Boston Scientific's Jang patents.
The dangers of passive smoking are even more pronounced among young people carrying common gene defects, researchers at the University of Dundee have found.
Independent research organisation MindMetre, which regularly addresses patient and healthcare worker safety across Europe, has examined evidence from qualitative interviews, clinical research and case studies that harm is being sustained by chemotherapy nurses in UK NHS Trusts as a result of exposure to hazardous cytotoxic drugs.
› Verified 9 days ago
Nancy E Campbell, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2230 E. Speedway Blvd., Suite 100, Tucson, AZ 85719 Phone: 520-878-7857 Fax: 520-572-2049 | |
Counterpoint Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1661 N Swan Rd Ste 200-2, Tucson, AZ 85712 Phone: 520-990-3122 | |
Counseling Directions Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1001 N Alvernon Way Ste 105, Tucson, AZ 85711 Phone: 520-561-8773 | |
Perception Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1213 E Warehouse Avenue, Tucson, AZ 85719 Phone: 520-623-7077 | |
B. Robert Crago Phd Pc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 5363 E Pima St Ste 100, Tucson, AZ 85712 Phone: 520-323-0062 Fax: 520-323-1336 | |
Catalina Behavioral Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 16358 N Forecastle Ave, Tucson, AZ 85739 Phone: 602-367-9807 |